2024 Shortlist
Best ADC Platform Technology:
Abzena - ThioBridge
Ajinomoto Biopharma Services - AJICAP
Ambrx, a J&J Company – Expanded Genetic Code Technology Platform
Catalent - SMARTag Technology
Daiichi Sankyo – DXd ADC Technology
Duality Biologics – DITAC & DIMAC Technology
LigaChem - Scaffold Based Approach / ConjuAll
Sichuan Kelun-Biotech - optiDC
WuXi XDC - WuXiDAR4 Platform
Best New Drug Developer:
BioNTech
Duality Biologics
Exelixis
LigaChem
MBrace Therapeutics
ProfoundBio (Genmab)
Sichuan Kelun-Biotech
Most Promising Clinical Candidate:
ABBV-400 – AbbVie
BL-B01D1 - SystImmune
Ifinatamab Deruxtecan (I-DXd) – Daiichi Sankyo
LCB 84 – LigaChem
MBRC-101 - MBrace Therapeutics
OBI-992 - OBI Pharma
Raludotatug Deruxtecan (R-DXd) – Daiichi Sankyo
Sacituzumab Tirumotecan - Sichuan Kelun-Biotech/ MSD
Best Contract Research Organization:
Abzena
Charles River
ChemExpress
Crown Bioscience
NJ Bio
PPD
WuXi XDC
Best Contract Manufacturing Development Organization:
Abzena
AsymBio
Aton Biotech
BSP Pharmaceuticals
Cerbios-Pharma SA
Lonza
MilliporeSigma
Simtra BioPharma Solutions
WuXi XDC